Page last updated: 2024-09-03

ro 32-0432 and mecamylamine

ro 32-0432 has been researched along with mecamylamine in 1 studies

Compound Research Comparison

Studies
(ro 32-0432)
Trials
(ro 32-0432)
Recent Studies (post-2010)
(ro 32-0432)
Studies
(mecamylamine)
Trials
(mecamylamine)
Recent Studies (post-2010) (mecamylamine)
560131,99768376

Protein Interaction Comparison

ProteinTaxonomyro 32-0432 (IC50)mecamylamine (IC50)
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)0.44
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)2.0833
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)1.6133
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)1.8
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)0.6
Neuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)3.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arora, S; Rehni, AK; Singh, TG1

Other Studies

1 other study(ies) available for ro 32-0432 and mecamylamine

ArticleYear
Ro 32-0432 attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:3

    Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; G-Protein-Coupled Receptor Kinase 5; Indoles; Male; Maze Learning; Mecamylamine; Mice; Nicotine; Pyrroles; Substance Withdrawal Syndrome

2013